Pheton (PTHL) Competitors $0.79 +0.03 (+4.37%) Closing price 09/26/2025 04:00 PM EasternExtended Trading$0.78 -0.01 (-0.76%) As of 09/26/2025 07:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock PTHL vs. NXGL, IRIX, CTCX, NVNO, ALUR, CODX, OSRH, NXL, IINN, and BTCYShould you be buying Pheton stock or one of its competitors? The main competitors of Pheton include NexGel (NXGL), IRIDEX (IRIX), Carmell (CTCX), enVVeno Medical (NVNO), Allurion Technologies (ALUR), Co-Diagnostics (CODX), OSR (OSRH), Nexalin Technology (NXL), Inspira Technologies OXY B.H.N. (IINN), and Biotricity (BTCY). These companies are all part of the "medical equipment" industry. Pheton vs. Its Competitors NexGel IRIDEX Carmell enVVeno Medical Allurion Technologies Co-Diagnostics OSR Nexalin Technology Inspira Technologies OXY B.H.N. Biotricity Pheton (NASDAQ:PTHL) and NexGel (NASDAQ:NXGL) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings. Which has better valuation and earnings, PTHL or NXGL? Pheton has higher earnings, but lower revenue than NexGel. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPheton$450K11.57-$660KN/AN/ANexGel$8.69M2.23-$3.28M-$0.40-6.00 Do insiders & institutionals hold more shares of PTHL or NXGL? 2.2% of NexGel shares are held by institutional investors. 20.6% of NexGel shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is PTHL or NXGL more profitable? Pheton has a net margin of 0.00% compared to NexGel's net margin of -25.02%. Pheton's return on equity of 0.00% beat NexGel's return on equity.Company Net Margins Return on Equity Return on Assets PhetonN/A N/A N/A NexGel -25.02%-49.37%-25.68% Does the media favor PTHL or NXGL? In the previous week, Pheton had 1 more articles in the media than NexGel. MarketBeat recorded 2 mentions for Pheton and 1 mentions for NexGel. NexGel's average media sentiment score of 1.91 beat Pheton's score of 0.95 indicating that NexGel is being referred to more favorably in the news media. Company Overall Sentiment Pheton Positive NexGel Very Positive SummaryPheton beats NexGel on 6 of the 10 factors compared between the two stocks. Get Pheton News Delivered to You Automatically Sign up to receive the latest news and ratings for PTHL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PTHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PTHL vs. The Competition Export to ExcelMetricPhetonMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.21M$7.61B$5.71B$10.40BDividend YieldN/A2.83%5.78%4.69%P/E RatioN/A72.5376.3626.24Price / Sales11.5739.50564.46126.78Price / CashN/A22.5225.6330.64Price / Book0.846.6712.406.38Net Income-$660K$244.98M$3.31B$274.27M7 Day Performance-8.09%-1.34%1.29%0.34%1 Month Performance5.40%0.25%3.71%5.77%1 Year Performance-83.62%7.29%62.66%27.44% Pheton Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PTHLPhetonN/A$0.79+4.4%N/A-83.6%$5.21M$450K0.0011NXGLNexGel0.7571 of 5 stars$2.53-2.7%N/A-7.3%$20.98M$8.69M-6.3210IRIXIRIDEX0.8343 of 5 stars$1.15-3.4%N/A-35.8%$20.22M$48.67M-3.48120Gap DownHigh Trading VolumeCTCXCarmellN/A$0.90-10.1%N/A+100.0%$18.76M$32.84K0.0014Gap DownNVNOenVVeno Medical0.8012 of 5 stars$0.92-1.2%N/A-70.1%$17.96MN/A-0.7730News CoverageALURAllurion Technologies1.7729 of 5 stars$2.25+2.0%$22.83+917.1%-86.8%$17.08M$32.11M-0.18501News CoverageNegative NewsCODXCo-Diagnostics4.2675 of 5 stars$0.42-4.2%$5.50+1,211.4%-68.8%$16.87M$3.91M-0.36100Positive NewsOSRHOSRN/A$0.74-2.7%N/AN/A$16.33MN/A0.00N/APositive NewsGap UpNXLNexalin Technology1.912 of 5 stars$0.96+2.7%$5.00+420.8%+32.6%$16.28M$170K-1.263News CoverageIINNInspira Technologies OXY B.H.N.1.7643 of 5 stars$1.26+1.6%$2.00+58.7%-5.8%$15.65MN/A0.0020Positive NewsBTCYBiotricityN/A$0.61-2.4%N/A+136.0%$15.31M$12.06M-0.5740 Related Companies and Tools Related Companies NexGel Alternatives IRIDEX Alternatives Carmell Alternatives enVVeno Medical Alternatives Allurion Technologies Alternatives Co-Diagnostics Alternatives OSR Alternatives Nexalin Technology Alternatives Inspira Technologies OXY B.H.N. Alternatives Biotricity Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PTHL) was last updated on 9/28/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredThis is the “End of Tesla” as we know it…Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pheton Holdings Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Pheton With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.